Medicinova Inc (MNOV)

1.46 +8.15%

Medicinova Inc (MNOV) is currently trading at $1.46. This represents a gain of 8.15% from the previous session. With a market capitalization of $0.07B, MNOV is a key component of the Health Care sector. Investors looking to trade MNOV should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Get 15 Free Stocks on Moomoo → T&Cs Apply. Trade MNOV commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Medicinova Inc (MNOV) shows a bullish trend. Analysts are watching the 1.52 level closely.

Fundamentals
Mkt Cap0.07B
P/E Ratio0.0000
Volume44,575
Others Watching (By Market Cap)
SGMO
Sangamo Therape $0.48
+1.86% ABOS
Acumen Pharmace $2.74
-0.72% INGN
Inogen Inc $5.97
+2.23% ANIK
Anika Therapeut $10.89
+0.35% RCEL
AVITA Medical I $5.04
-6.47%
60-Day Technical Chart
Advanced Charting

Need more indicators for MNOV? Use the world's #1 platform.

Open MNOV on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $1
Metric MNOV
+8.15% 		RXT
-4.45% 		GORO
-4.87% 		LXRX
+1.35%
Price $1.46 $1.40 $1.47 $1.50
Mkt Cap $0.07B $0.34B $0.24B $0.65B
- View → View → View →
Latest Headlines
Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading? Benzinga • Oct 30, 2025 MediciNova Stock Rockets 85% After-Hours On Promising Heart Study — Traders Hope For ‘Big Green Candle’ Stocktwits • Oct 30, 2025 ALS patients gain wider access as MediciNova trial reaches 100 enrollees Stock Titan • Jan 29, 2026 MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication GlobeNewswire • Oct 30, 2025 MediciNova (NASDAQ: MNOV) names FDA expert Dr. Breder clinical and regulatory advisor Stock Titan • Nov 18, 2025
● Gemini Agentic AI Analyst Insight for MNOV
Market Education
View All Articles →
External Research